Gustaf Ahlen

Stockholm, AB 14186, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets.

Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 17, 2025

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Journal: Molecular therapy. Advances

Published: July 05, 2025

Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.

Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.

Journal: Gastroenterology

Published: July 10, 2023

Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.

Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 08, 2023

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

Journal: Immuno-oncology technology

Published: November 17, 2022

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 22, 2022

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Journal: Gut

Published: February 18, 2022

A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.

A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.

Journal: EMBO molecular medicine

Published: February 04, 2022

Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.

Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.

Journal: Journal of virology

Published: November 24, 2021

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.

Journal: Molecular & cellular proteomics : MCP

Published: June 14, 2021

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

Journal: Clinical & translational immunology

Published: March 30, 2021

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.

Journal: Journal of virology

Published: July 15, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026